Skip to main content

Laparoscopic Cholecystectomy

0
Pipeline Programs
5
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Stryker
StrykerCA - San Jose
1 program
LED light source system for endoscopeN/A1 trial
Active Trials
NCT04561583Withdrawn0Est. Sep 2021
Intuitive Surgical
Intuitive SurgicalCA - Sunnyvale
1 program
Laparoscopic cholecystectomyN/A1 trial
Active Trials
NCT04888117Completed186Est. Jan 2025
Alesi Surgical
Alesi SurgicalUK - Cardiff
1 program
Smoke management during laparoscopic cholecystectomy using the Ultravision™ SystemN/A1 trial
Active Trials
NCT04162106Unknown60Est. Feb 2020
Sana Health
Sana HealthCO - Louisville
1 program
dexmedetomidineN/A1 trial
Active Trials
NCT04138472Unknown30Est. Feb 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Intuitive SurgicalLaparoscopic cholecystectomy
StrykerLED light source system for endoscope
Alesi SurgicalSmoke management during laparoscopic cholecystectomy using the Ultravision™ System
Sana Healthdexmedetomidine

Clinical Trials (4)

Total enrollment: 276 patients across 4 trials

NCT04888117Intuitive SurgicalLaparoscopic cholecystectomy

Prospective Multi-Center Study of Short-Term Outcomes After Complex Cholecystectomy

Start: Jun 2021Est. completion: Jan 2025186 patients
N/ACompleted
NCT04561583StrykerLED light source system for endoscope

Effectiveness and Safety of LED Light Source System for Endoscope

Start: Sep 2020Est. completion: Sep 20210
N/AWithdrawn
NCT04162106Alesi SurgicalSmoke management during laparoscopic cholecystectomy using the Ultravision™ System

Feasibility of the Ultravision™ System in Low Pressure Laparoscopic Cholecystectomy Compared to Airseal® IFS

Start: Nov 2019Est. completion: Feb 202060 patients
N/AUnknown
NCT04138472Sana Healthdexmedetomidine

Comparison Of Dexmedetomidine, Fentanyl And Lignocaine In Attenuation Of Hemodynamic Response To Direct Laryngoscopy And Intubation In Patient Undergoing Laparoscopic Cholecystectomy

Start: Oct 2019Est. completion: Feb 202030 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.